gadolinium dtpa has been researched along with isoniazid in 1 studies
Studies (gadolinium dtpa) | Trials (gadolinium dtpa) | Recent Studies (post-2010) (gadolinium dtpa) | Studies (isoniazid) | Trials (isoniazid) | Recent Studies (post-2010) (isoniazid) |
---|---|---|---|---|---|
12,654 | 664 | 4,051 | 21,815 | 960 | 4,493 |
Protein | Taxonomy | gadolinium dtpa (IC50) | isoniazid (IC50) |
---|---|---|---|
Myeloperoxidase | Homo sapiens (human) | 4.85 | |
Enoyl-[acyl-carrier-protein] reductase [NADH] | Mycobacterium tuberculosis H37Rv | 8.29 | |
Putative FAD-containing monooxygenase MymA | Mycobacterium tuberculosis H37Rv | 4.9 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Handa, J; Kizuki, H; Takebe, Y; Tokuriki, Y; Tsuji, A | 1 |
1 other study(ies) available for gadolinium dtpa and isoniazid
Article | Year |
---|---|
[Treatment of tuberculous meningitis: marker of cure].
Topics: Adenosine Deaminase; Antitubercular Agents; Biomarkers; Gadolinium DTPA; Humans; Isoniazid; Magnetic Resonance Imaging; Male; Middle Aged; Rifampin; Streptomycin; Tuberculosis, Meningeal | 1998 |